• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Lothar Heinemann

  • share 
  • tweet 
  • share 
  • share 

Publications

Heinemann Lothar A , Do Minh Thai, Heinemann Klaas, Lindemann M , Filonenko A, Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities. Health Care Women International. 2012; Feb;33(2):109-24.
Heinemann Klaas, Heinemann Lothar A , Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.. J Fam Plann Reprod Health Care. 2011; Jul;37(3):132-5. 10.1136/jfprhc-2011-14524.
Heinemann Lothar A , Do Minh Thai, Filonenko A, Uhl-Hochgräber K, Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. The Patient. Patient-Centered Outcomes Research. 2010; 3(2):113-123.
Heinemann Lothar A , Explorative evaluation of the impact of severe premenstrual disorder on work absenteeism and productivity. Women's Health Issues. 2010; 20(1):58-65..
Heinemann Lothar A , Dinger Jürgen, Assmann Anita, Do Minh Thai, Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare" Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014.
Heinemann Lothar A , Key findings of the IMPACT study. Gynaecology Forum. 2009; 14(3): 9-13..
Heinemann Lothar A , Damonte Khoury C, Assessment of health-related quality of life and economic effect in patients with premenstrual disorders. Obstet Gynecol. 2009; 111(4) (Supplement Poster abstracts): 13S.
Damonte Khoury C, Heinemann Lothar A , Assessment of HRQoL and economic impact in patients with premenstrual disorders. Obstet Gynecol. 2009; 111(4) (Supplement Poster abstracts).
Heinemann Lothar A , Damonte Khoury C, Assessment of the impact of severe premenstrual disorders on work absenteeism and productivity. 10th Congress of the European Society of Contraception. 2008; Prague, April 30 - May 3 2008.
Michielsen P, Heinemann Lothar A , Mihatsch M, Schnülle P, Graf H, Koch KM, Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case-control study. NDT Advance Access. 2008; doi:10.1093/ndt/gfn643.
Heinemann Klaas, Rübig A, Strothmann A, Nahum GG, Heinemann Lothar A , Prevalence and opinions of hormone therapy prior to the Women’s Health Initiative: a multinational survey in four continents. J Women’s Health. 2008; 17:1-16.
Assmann Anita, Dinger Jürgen, Filonenko A, Do Minh Thai, Heinemann Lothar A , Impact of severe premenstrual disorders on work, daily life, social relations, and quality of life: preliminary results of a multinational follow-up study. Pharmacoepidemiol Drug Saf. 2008; 17: S116.
Raff T, Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.
Behre H M, Heinemann Lothar A , Morales A, Pexman-Fieth C, Rationale, design and methods of the esprit study: energy, sexual desire and body proportions with AndroGel, Testosterone 1% gel therapy, in hypogonadal men. The Aging Male. 2008; 11:101-106.
van der Woude Fokke J , Heinemann Lothar A , Graf H, Lewis Michael, Moehner Sabine, Assmann Anita, Kuehl-Habich D, Analgesics use and ESRD in younger age: a case-control study BMC Nephrology. 2007; 8:15.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.
Heinemann Lothar A , Dinger Jürgen, Range of published estimates of VTE incidence in young women Contraception. 2007; 75: 3328-336.
Dinger Jürgen, Heinemann Lothar A , Kuehl-Habich D, The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance study on Oral Contraceptives (EURAS-OC) based on 142,475 women-years of observation Contraception. 2007; DOI: 10.1016/j.contraception.2006.12.019.
Heinemann Lothar A , HPG – initiator & facilitator: the Menopause Rating Scale (MRS). HPG Schneider (Ed) Ein Vierteljahhundert Frauenheilkunde und Gebortshilfe aus Münsteraner Sicht. Hanser & Co GmbH, Münster. 2007; p. 198-203.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Heinemann Lothar A , Westhoff C, Final results from the EURAS study: impact of oral contraception on public health. Obstet Gynecol. 2007; 109(4): 5S.
Dinger Jürgen, Heinemann Lothar A , Westhoff C, First results from the international active surveillance study on oral contraceptives (INAS-OC). Obstet Gynecol. 2007; 109(4): 58S.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The safety and efficacy of oral contraceptives in teenagers: results from the EURAS-OC study. Pharmacoepidemiology and Drug Safety. 2007; 16: S13.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Interim results from the international active surveillance study of women taking oral contraceptives (INAS OC). Pharmacoepidemiology and Drug Safety. 2007; 16: S211.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , Design issues in active surveillance studies: experience from the EURAS studies.. Pharmacoepidemiology and Drug Safety. 2007; 16: S253.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Women's Health. 2006; 6:13.
Heinemann Lothar A , Moore C, Dinger Jürgen, Stoehr D, Sensitivity as outcome measure of androgen replacement: the AMS scale. Health and Quality of Life Outcomes. 2006; 4:23.
Dinger Jürgen, Zimmermann T, Heinemann Lothar A , Stoehr D, Quality of life and hormone use: new validation results of MRS scale. Health and Quality of Life Outcomes. 2006; 4:32.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Thiel C, The risk of gynaecological cancers associated with different HRT formulations. A nested case-control study in the German Cohort Study on Women’s Health. Geburth Frauenheilk. 2006; 66:145-155.
Dinger Jürgen, Heinemann Lothar A , European Active Surveillance Study of Women taking HRT (EURAS-HRT): study protocol BMC Women's Health. 2006; 6:1. DOI: 10.1186/1472-6874-6-1.
Heinemann Lothar A , Dinger Jürgen, Klinische Studien – eine Evidenzfalle?. Frauenarzt. 2006; 47:331-35.l.
Heinemann Lothar A , Assmann Anita, Dinger Jürgen, The risk of venous thromboembolism (VTE) in oral contraceptives: a new lesson. Pharmacoepidemiology and Drug Safety. 2006; 15: S24.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The European active surveillance study on oral contraceptives (EURAS-OC): final results after more than 130,000 WY of observatio. Pharmacoepidemiology and Drug Safety. 2006; 15: S26.
Assmann Anita, Dinger Jürgen, Heinemann Lothar A , European active surveillance of women taking HRT (EURAS-HRT). Pharmacoepidemiology and Drug Safety. 2006; 15: S73.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , International active surveillance study of women taking oral contraceptives (INAS-OC). Pharmacoepidemiology and Drug Safety. 2006; 15: S132.
Dinger Jürgen, Assmann Anita, Heinemann Lothar A , The impact of obesity on the contraceptive reliability of oral contraceptives. Pharmacoepidemiology and Drug Safety. 2006; 15: S140.
Heinemann Lothar A , Dinger Jürgen, The menopause rating scale (MRS) as outcome measure for hormone treatment. Pharmacoepidemiology and Drug Safety. 2006; 14: S44.
Heinemann Lothar A , Aging Males' Symptoms scale: a standardized instrument for the practice. J Endocrinol Invest. 2005; 28: 34-38.
Heinemann Lothar A , Schneider HPG, Quality of life assessment in the menopause. Eskin B (Ed) The Menopause: Endocrinologic Basis & Management Options. 5th edition. Taylor & Francis Medical Books,London (Manuscript in print). 2005;
Myon E, Martin N, Taïeb C, Heinemann Lothar A , Experiences with the French Aging Males' Symptoms (AMS) scale. Aging Male. 2005; 8(3/4):184-189.
Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A, Heinemann Lothar A , Harmonized Italian version of the Aging Males' Symptoms scale. Aging Male. 2005; 8(3/4):180-183.
Kratzik C, Heinemann Lothar A , Saad F, Do Minh Thai, Rücklinger E, Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male. 2005; 8 (3/4):157-161.
Heinemann Klaas, Saad F, Wiesemes M, Heinemann Lothar A , Expectations towards a novel MFC and potential user types. Results of a multinational survey. J Andrology. 2005; 26(2): 155-62.
Heinemann Klaas, Saad F, Wiesemes M, Heinemann Lothar A , Attitudes toward male fertility control; a multinational survey in four continents. Human Reproduction. 2005; 20 (2): 549-56.
Spannagl M, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8.
Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Hilpert J, Spannagl M, VTE risk assessment – a prognostic model: BATER cohort study of young women Thrombosis Journal. 2005; 2005;3:5 (18 April 2005). DOI: 10.1186/1477-9560-3-5.
Heinemann Lothar A , Potthoff P, Heinemann Klaas, Pauls Alfred, Ahlers C J, Saad F, Scale for Quality of Sexual Function (QSF) as an outcome measure for both genders?. J Sex Med. 2005; 2:82-95.
Heinemann Lothar A , Garbe E, Lewis Michael, van der Woude F, Graf H, Case-control study on analgesics and nephropathy (SAN): protocol BMC Nephrology. 2005; 6:9 (8 August 2005). DOI: 10.1186/1471-2369-6-9.
Heinemann Lothar A , Dinger Jürgen, Safety of a new oral contraceptive containing drospirenone Drug Safety. 2004; 27(13):1001-18.
Heinemann Lothar A , Recent results on HRT: Problems encountered by an epidemiologist. Menopause Review. 2004; 9:7-12.
Heinemann Lothar A , WHI-Studie und Million Women Study aus epidemiologischer Sicht. Frauenarzt. 2004; 45 (3):217-22.
Heinemann Lothar A , Saad F, Heinemann Klaas, Do Minh Thai, Can results of the AMS scale predict those of screening scales for androgen deficiency?. Aging Male. 2004; 7:211-18.
Moore C, Huebler D, Zimmermann T, Heinemann Lothar A , Saad F, Do Minh Thai, The AMS scale as outcome measure for treatment of androgen deficiency Eur Urology. 2004; 46:80-7.
Heinemann Klaas, Alexander Ruebig Alexander, Potthoff P, Schneider HPG, Strelow Frank, Heinemann Lothar A , Do Minh Thai, The Menopause Rating Scale: A methodological review. Health and Quality of Life Outcomes. 2004; 2:45 (2 September 2004). 10.1186/1477-7525-2-45.
Potthoff P, Heinemann Lothar A , A household panel as a tool for cost-effective health-related population surveys: validity of the “Healthcare Access Panel”. German Medical Science. 2004; 2:Doc05/20040716/.
Heinemann Lothar A , Do Minh Thai, Strelow Frank, Gerbsch Silvia, Schnitker Jörg, Schneider HPG, The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? Health and Quality of Life Outcome. 2004; 2:67. Doi:10.1186/1477-7525-2-67.
Heinemann Lothar A , Saad F, The aging male’s symptoms scale. Schneider HPG (Ed.) Menopause. The state of the art – in research and management. The Parthenon Publishing Group. Boca Raton, London, New York, Washington. 2003; 319-324.
Heinemann Klaas, Thiel C, Lewis Michael, Raff T, Heinemann Lothar A , Benign gynecological tumors: estimated incidence. Results of the German Cohort study on Women’s Health Eur J Obst Gyn Reprod Biol. 2003; 107: 78-80.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Cancer of the uterus and ovary and lifetime history of oral contraceptive use. A German case-control study. Geburth.Frauenheilk. 2003; 63:1018-26.
Heinemann Lothar A , Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T’Sjoen G, Pöllänen P, Goncharow NP, Kim S, Giroudet C, The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions Health and Quality of Life Outcomes. 2003; 1: 15.. 10.1186/1477-7525-1-15.
Convay K , Heinemann Lothar A , Giroudet C, Johannes EJ, Myon E, Taieb C, Raynaud JP, Harmonized French version of the Aging Males’ Symptoms Scale Aging Male. 2003; Jun;6(2):106-9.
Heinemann Lothar A , Potthoff P, Schneider HPG, International versions of the Menopause Rating Scale (MRS) Health and Quality of Life Outcomes. 2003; 1:28 (30 July 2003). 10.1186/1477-7525-1-28.
Daig I , Heinemann Lothar A , Kim S, Leungwattanakij S, Badia X, Myon E, Saad F, Potthoff P, Do Minh Thai, The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics Health and Quality of Life Outcomes. 2003; 1:77 (December 2003). 10.1186/1477-7525-1-77.
Heinemann Lothar A , Pöllänen P, Saad F, Measurement of quality of life specific for aging males. Schneider HPG (Ed.) Hormone Replacement Therapy and Quality of Life. Parthenon Publishing Group. London, New York, Washington. 2002; 63-83.
Schneider HPG, Heinemann Lothar A , Thiele K , The Menopause Rating Scale (MRS): cultural and linguistic translation into English. Life and Medical Science Online. 2002; 3. DOI:101072/LO0305326.
Heinemann Lothar A , Kluft C, Spannagl M, De Maat M P M, The association between extrinsic APC resistance and venous thromboembolism in women Contraception. 2002; 66: 297-304.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, Garbe E, Lifetime history of oral contraceptive use and development of the uterus and ovary. Geburth Frauenheilk. 2002; 62:566-573. DOI: 10.1055/s-2002-32421.
Heinemann Lothar A , Lewis Michael, Kuehl-Habich D, Braendle W, The risk of breast tumors and lifetime history of oral contraceptive use Geburtshilfe und Frauenheilkund. 2002; 62(8):750-757.
Heinemann Klaas, Assmann Anita, Lewis Michael, Garbe E, Heinemann Lothar A , Teichmann A T, Trend der HRT Nutzung in Deutschland 1980-1999. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. 2002; 43:508-511.
Heinemann Klaas, Lewis Michael, Assmann Anita, Garbe E, Heinemann Lothar A , Trend der OC-Nutzung in einer Deutschen Frauen-Kohorte 1980-1999 Zentralbl Gynakol. 2002; 124(2): 128-131. DOI: 10.1055/s-2002-24241.
Heinemann Klaas, Heinemann Lothar A , Assmann Anita, Schneider HPG, Reliabilität der Menopause-Rating-Skala (MRS). Untersuchung für die Deutsche Bevölkerung Zentralbl Gynakol. 2002; 124(3): 161-163. DOI: 10.1055/s-2002-32268.
Heinemann Lothar A , Assmann Anita, European Active Surveillance Study on Hormone Replacement Therapy. EURAS-HRT study protocol. Life and Medical Science Online. 2002; 3.
Heinemann Lothar A , Lewis Michael, Assmann Anita, Thiel C, Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use Contraception. 2002; Mar;65(3):207-14.
Burkman R T, Heinemann Lothar A , Progestins and thrombosis Dialogues in Contraception. 2001; Winter; 7(3):5-7, 8.
Heinemann Lothar A , Aufgebauschte Risikoszenarien (Editorial). Gyno Panorama. 2001; 2:2-3.
Heinemann Lothar A , Saad F, Thiele K , Wood-Dauphinee S, The Aging Males' Symptoms rating scale: cultural and linguistic validation into English 2001; Volume 4, 2001 - Issue 1.
Thiel C, Heinemann Lothar A , Assmann Anita, Gründe für eine Veränderung der HRT-Therapie aus Sicht der Frauen. Zentralblatt für Gynäkologie . 2001; 123(7):390-398. DOI: 10.1055/s-2001-17036.
Heinemann Lothar A , Thiel C, Assmann Anita, Gründe und Häufigkeit von Wechsel/Stopp der Einnahme oraler Kontrazeptiva. Ergebnisse der Deutschen Kohortenstudie zur Frauengesundheit. Zentralbl Gynakol. 2001; 123(10): 568-577. DOI: 10.1055/s-2001-19090.
Heinemann Lothar A , Assmann Anita, Lewis Michael, How representative can be a cohort of volunteers for the general population? The German Cohort Study on Women' Health. Life and Medical Science Online. 2001; 2.
Heinemann Lothar A , Assmann Anita, Heinemann Klaas, Use of oral contraceptives containing dienogest and risk of venous thromboembolism; an extended summary report. Life and Medical Science Online. 2001; 2.
Suissa S, Spitzer WO, Rainville B, Cusson J , Lewis Michael, Heinemann Lothar A , Recurrent use of newer oral contraceptives and the risk of venous thromboembolism Hum Reprod. 2001; Apr;15(4):817-21.
Heinemann Lothar A , Garbe E, Farmer R, Lewis Michael, Venous thromboembolism and oral contraceptive use: a methodological study of diagnostic suspicion and referral bias Eur J Contracept Reprod Health Care. 2001;
Feinstein A R, Heinemann Lothar A , Curhan GC, Delzell E, DeSchepper PJ, Fox JM, Graf H, Luft FC, Michielsen P, Mihatsch MJ, Suissa S, Van der Woude F, Willich S, The relationship between non-phenacetin combined analegesics and nephropathy: a review Kidney International. 2001; 58: 2259-2264.
Heinemann Lothar A , Thiel C, Assmann Anita, Zimmermann T, Hummel W, Vermeulen A, Sex differences of „climacteric symptoms“ with increasing age? A pooled analysis of cross-sectional population-based surveys Aging Male. 2001; Sep;3(3):124-31.
Feinstein A R, Heinemann Lothar A , Dalessio D, Fox JM, Goldstein J, Haag G, Ladewig D, O'Brien C P , Do caffeine-containing analgesics promote dependence? A review and evaluation Clin Pharmacol Ther. 2001; 68(5):457-67. 10.1067/mcp.2000.110974.
Heinemann Lothar A , Emerging evidence on oral contraceptives and arterial diseases. Proceeding of the symposium on oral contraceptives and cardiovascular disease. Contraception. 2001; 62:29S-36S(Suppl).
Follman M, Heinemann Lothar A , Bauerfeind Anja, Garbe E, Treatment with potentially hepatotoxic drugs and the risk of hepatocellular carcinoma: results of a European case - control study. Pharmacoepidemiol Drug Saf . 2000; 9:417-22.
Schramm W, Heinemann Lothar A , Spannagl M, Dick A, Assmann Anita, Die BAyerischen Thrombo-Embolie-Risiko Kohortenstudie (BATER). Studienprotokoll, Stand der Untersuchung und erste Ergebnisse.. Dtsch Med Wschr. 2000; 125:2-6.
Garbe E, Heinemann Lothar A , Nichtkontrazeptiver Nutzen der Pille - ein oft unbeachteter Fakt Eine Übersicht zum gegenwärtigen Wissensstand. Zentralbl Gynako. 2000; 122:18-27.
Heinemann Lothar A , Garbe E, Winkler U, Rabe T, Die Deutsche Kohortenstudie zur Frauengesundheit: Zum Nutzen von oralen Kontrazeptiva. Ausführungen zum Studienprotokoll. Zentralbl Gynakol. 2000; 122: 112-115.
Schneider HPG, Heinemann Lothar A , osemeier HP, Hauser G A, Potthoff P, Behre H M , The Menopause Rating Scale (MRS): Reliability of scores of menopausal complaints Climacteric. 2000; 3(1):59-64..
Schnülle P, Schneider HPG, Heinemann Lothar A , osemeier HP, Hauser G A, Potthoff P, Behre H M , The Menopause Rating Scale (MRS): comparison with Kupperman Index and quality of life scale SF-36 Climacteric. 2000; Mar;3(1):50-8.
Spannagl M, Heinemann Lothar A , Schramm W, Are FVL carriers using OC at extreme risk for VTE ?. Eur J Contracept Reprod Hlth Care. 2000; 5:105-112.
Suissa S, Heinemann Lothar A , Spitzer WO, Rainville B, Cusson J , Lewis Michael, Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod. 2000; Apr;15(4):817-21.
Heinemann Klaas, Heinemann Lothar A , Do Minh Thai, Möhner M, Heuchert G E, Occupational exposure and liver cancer in women: results of the Multicentre International Liver Tumour Study (MILTS). Occup Med (Lond). 2000; Aug;50(6):422-9.
Heinemann Lothar A , Thorogood M, Kerle K M, Assmann Anita, Do Minh Thai, Use of psychotropic drugs and risk of cardiovascular events. Life and Medical Science Online. 2000; 1.

sidebar

Executive Team

  • Clare Barnett
  • Karl Pauls
  • Michael Schultze
  • Alfred Pauls
  • Anja Bauerfeind
  • Do Minh Thai
  • Elisabeth Finger
  • Jens A. Lange

Management Board

  • Klaas Heinemann
  • Clare Barnett
  • Marc Pignot
  • Karl Pauls
  • Johanna Poppe

Project Management Team

  • Pauline De Corte
  • Lisa Eggebrecht
  • Maria Cabral
  • Anitha Pitchika
  • Mohammed Dagher

Search

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.